Approval · Notice of Compliance 1595 · 1999
OPTISON: Notice of Compliance 1595
Issued February 2, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1595
- Date
- February 2, 1999
- Company
- Mallinckrodt MedicalAthlone, WM, Ireland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Intravenous ultrasound contrast medium
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTISON | 02239574 | Cancelled Post Market |
Medicinal ingredients
- ALBUMIN (HUMAN) 5 PER